{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:25:24Z","timestamp":1788121524898,"version":"build-2803163510"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["1336\/2017"],"award-info":[{"award-number":["1336\/2017"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229873","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:36:00Z","timestamp":1583433360000},"page":"e0229873","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-5633","authenticated-orcid":true,"given":"Gell\u00e9rt Bal\u00e1zs","family":"Karvaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriszti\u00e1n","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6843-7159","authenticated-orcid":true,"given":"Istv\u00e1n","family":"Vincze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barna","family":"V\u00e1s\u00e1rhelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Jelliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"pone.0229873.ref001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1875692111201010022","article-title":"Role of statistical random-effects linear models in personalized medicine","volume":"10","author":"FJ Diaz","year":"2012","journal-title":"Curr Pharmacogenom Pers Med"},{"key":"pone.0229873.ref002","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2710.2010.01215.x","article-title":"Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy","volume":"36","author":"IB Bondareva","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"pone.0229873.ref003","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualized antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"JA Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"pone.0229873.ref004","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/AAC.02025-12","article-title":"Software for dosage individualization of voriconazole for immunocompromised patients","volume":"57","author":"WW Hope","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0229873.ref005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1051\/ijmqe\/2012010","article-title":"Least-squares fitting with errors in the response and predictors","volume":"3","author":"T Burr","year":"2012","journal-title":"Int J Metrol Qual Eng"},{"key":"pone.0229873.ref006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-803348-7.00004-6","volume-title":"Individualized Drug Therapy for Patients","author":"RW Jelliffe","year":"2017"},{"key":"pone.0229873.ref007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1570-0232(02)00244-1","article-title":"Linear regression for calibration lines revisited: Weighting schemes for bioanalytical methods","volume":"774","author":"AM Almeida","year":"2002","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"pone.0229873.ref008","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","article-title":"Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS\/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay performance","volume":"86","author":"H Gu","year":"2014","journal-title":"Anal Chem"},{"key":"pone.0229873.ref009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0022-4731(72)90076-3","article-title":"The radioimmunoassay of aldosterone in serum and urine: theoretical and practical aspects","volume":"2","author":"RP Ekins","year":"1972","journal-title":"J Steroid Biochem"},{"key":"pone.0229873.ref010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/clinchem\/34.6.1058","article-title":"A method for direct estimation of imprecision profiles, with reference to immunoassay data","volume":"34","author":"WA Sadler","year":"1988","journal-title":"Clin Chem"},{"key":"pone.0229873.ref011","first-page":"517","article-title":"Pharmacoinformatics: equations for serum drug assay patterns; implications of therapeutic drug monitoring and dosage","author":"RW Jelliffe","year":"1993","journal-title":"Proc Annu Symp Comput Appl Med Care"},{"key":"pone.0229873.ref012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R","volume":"34","author":"MN Neely","year":"2012","journal-title":"Ther Drug Monit"},{"key":"pone.0229873.ref013","volume-title":"Individualized Drug Therapy for Patients","author":"RW Jelliffe","year":"2017"},{"key":"pone.0229873.ref014","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.clinbiochem.2016.05.001","article-title":"LC-MS\/MS as a tool for TDM services: Where are we?","volume":"49","author":"M Shipkova","year":"2016","journal-title":"Clin Biochem"},{"key":"pone.0229873.ref015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/FTD.0000000000000168","article-title":"Describing assay precision-reciprocal of variance is correct, not CV percent: its use should significantly improve laboratory performance","volume":"37","author":"RW Jelliffe","year":"2015","journal-title":"Ther Drug Monit"},{"key":"pone.0229873.ref016","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FTD.0000000000000470","article-title":"Influence of comedication on levetiracetam pharmacokinetics","volume":"40","author":"A Aldaz","year":"2018","journal-title":"Ther Drug Monit"},{"key":"pone.0229873.ref017","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1128\/AAC.01372-12","article-title":"Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection","volume":"57","author":"S Han","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0229873.ref018","unstructured":"Guideline on bioanalytical method validation (EMEA\/CHMP\/EWP\/192217\/2009 Rev. 1 Corr. 1**). European Medicine Agency, 2012. https:\/\/www.ema.europa.eu\/documen-ts\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf. Accessed: 6 Feb 2019."},{"key":"pone.0229873.ref019","first-page":"386","article-title":"A rank-invariant method of linear and polynomial regression analysis","volume":"53","author":"H Theil","year":"1950","journal-title":"Nederl Akad Wetensch Proc"},{"key":"pone.0229873.ref020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biomet\/69.1.242","article-title":"Robust regression using repeated medians","volume":"69","author":"AF Siegel","year":"1982","journal-title":"Biometrika"},{"key":"pone.0229873.ref021","doi-asserted-by":"crossref","DOI":"10.1007\/b97848","volume-title":"A distribution-free theory of nonparametric regression","author":"L Gy\u00f6rfi","year":"2002"},{"key":"pone.0229873.ref022","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/01621459.1968.10480934","article-title":"Estimates of the regression coefficient based on Kendall\u2019s tau","volume":"63","author":"PK Sen","year":"1968","journal-title":"J Am Stat Assoc"},{"key":"pone.0229873.ref023","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2014"},{"key":"pone.0229873.ref024","unstructured":"Ahn S, Fessler JA. Standard errors of mean, variance, and standard deviation estimators. Technical report. The University of Michigan, July 24, 2003. https:\/\/web.eecs.umich.edu\/~fessler\/papers\/files\/tr\/stderr.pdf."},{"key":"pone.0229873.ref025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.talanta.2011.09.059","article-title":"Theil-Sen nonparametric regression technique on univariate calibration, inverse regression and detection limits","volume":"87","author":"I Lavagnini","year":"2011","journal-title":"Talanta"},{"key":"pone.0229873.ref026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinms.2016.12.003","article-title":"A proposal to improve calibration and outlier detection in high-throughput mass spectrometry","volume":"2","author":"APR Zabell","year":"2016","journal-title":"Clin Mass Spectrom"},{"key":"pone.0229873.ref027","unstructured":"Bioanalytical method validation. Guidance for industry. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2018. https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070107.pdf. Accessed: 6 Feb 2019."},{"key":"pone.0229873.ref028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10928-007-9078-9","article-title":"Impact of censoring data below an arbitrary quantification limit on structural model misspecification","volume":"35","author":"W Byon","year":"2008","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"pone.0229873.ref029","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10928-011-9201-9","article-title":"Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models","volume":"38","author":"SX Xu","year":"2011","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"pone.0229873.ref030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pst.400","article-title":"Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data","volume":"9","author":"S Yang","year":"2010","journal-title":"Pharm Stat"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T19:11:35Z","timestamp":1614712295000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229873"}},"subtitle":[],"editor":[{"given":"Jed N.","family":"Lampe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229873","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]}}}